Paret
Claudia Paret, Mainz DE
Patent application number | Description | Published |
---|---|---|
20160058853 | INDIVIDUALIZED VACCINES FOR CANCER - The present invention relates to a patient-specific tumor treatment targeting individual expression patterns of tumor antigens, in particular shared tumor antigens, and individual tumor mutations. In one aspect, the present invention relates to a method for preventing or treating cancer in a patient comprising the steps of: (i) inducing a first immune response against one or more tumor antigens in the patient, and (ii) inducing a second immune response against one or more tumor antigens in the patient wherein the second immune response is specific for cancer specific somatic mutations present in cancer cells of the patient. | 03-03-2016 |
Nicolas Paret, Geneva CH
Patent application number | Description | Published |
---|---|---|
20130084456 | STABLE FORMALDEHYDE-FREE MICROCAPSULES - Water-dispersible core-shell microcapsules that are essentially free of formaldehyde. Also, oligomeric compositions of, and microcapsules obtained from, particular reaction products between a polyamine component and a particular mixture of glyoxal and a C | 04-04-2013 |
20140322283 | STABLE FORMALDEHYDE-FREE MICROCAPSULES - The present invention relates to water-dispersible core-shell microcapsules essentially free of formaldehyde. In particular it concerns core-shell microcapsules having a shell obtained by reacting polyisocyanates or polyoxirans cross-linkers and oligomeric compositions which are the reaction products between a polyamine component and a particular mixture of glyoxal and a C | 10-30-2014 |
20140342963 | STABLE FORMALDEHYDE-FREE MICROCAPSULES - The present invention relates to water-dispersible core-shell microcapsules essentially free of formaldehyde. In particular it concerns oligomeric compositions comprising, and the microcapsules obtained from, particular reaction product between a polyamine component and a particular mixture of glyoxal and a C | 11-20-2014 |
Nicolas Paret, Geneva 8 CH
Patent application number | Description | Published |
---|---|---|
20140275288 | PHOTOLABILE LATEX FOR THE RELEASE OF PERFUMES - The present invention relates to the field of perfumery. More particularly, it concerns co-polymeric latex particles derived from 2-oxo-2-(3- or 4-vinylphenyl)acetates capable of liberating an active molecule such as, for example, an aldehyde or ketone upon exposure to light. The present invention concerns also the use of said latex in perfumery as well as the perfuming compositions or perfumed articles comprising the invention's latex. | 09-18-2014 |
20140323376 | MICROCAPSULES AND USES THEREOF - The present invention relates to core-shell microcapsules comprising photolabile 2-oxoacetate pro-fragrance molecules capable of liberating an active molecule such as, for example, an aldehyde or ketone upon exposure to light. The present invention concerns also the use of said microcapsules in perfumery as well as the perfuming compositions or perfumed articles comprising the invention's microcapsules to provide a prolonged release of fragrant aldehydes and/or ketones. | 10-30-2014 |
Robert Paret, Oostende BE
Patent application number | Description | Published |
---|---|---|
20090287264 | APPLIANCE AND SEQUENCE OF PULSES FOR THE APPLICATION OF ELECTROTHERAPY - The invention relates to a transcutaneous nerve and/or muscle stimulation appliance with electrodes destined to apply a sequence of electric pulses to the skin of a person, providing means that allow the generation of multiphase pulses during a stimulation period, these means allowing the generation of successive sequences of the above-mentioned multiphase pulses during successive stimulation periods with a frequency between 10 Hz and 100 Hz, more in particular a frequency of approximately 50 Hz, these means furthermore allowing a rest period between successive stimulation periods, during which rest period a sequence of electric pulses is generated with a frequency ranging from 0.5 Hz to 5 Hz and with an amplitude lower than that of the above-mentioned multiphase pulses. | 11-19-2009 |